Bio-Rad Laboratories | Passifs Courants



Current Liabilities Changement Date
Abbott USD 14.16B 745M 2024-12
Agilent USD 1.87B 26M 2025-01
Becton, Dickinson and Co. USD 7.66B 1.29B 2024-12
Bio Techne USD 161.26M 19.13M 2024-12
Bio-Rad Laboratories USD 467.8M 30.14M 2024-12
Bruker USD 1.28B 37.5M 2024-12
Charles River Laboratories USD 994.1M 18.12M 2024-12
Danaher USD 6.8B 541M 2024-12
Exact Sciences USD 732.19M 8.52M 2024-12
General Electric USD 34.39B 299M 2024-12
Hologic USD 1B 34.8M 2024-12
Illumina USD 1.55B 572M 2024-12
IQVIA Holdings USD 6.96B 35M 2024-12
Laboratory Of America USD 3.33B 81.8M 2024-12
Merck USD 28.42B 1.17B 2024-12
Mettler Toledo International USD 1.17B 16.77M 2024-12
Myriad Genetics USD 164.1M 9.8M 2024-12
Quest Diagnostics USD 2.17B 77M 2024-12
Repligen USD 108.37M 65.94M 2024-09
Revvity USD 653.1M 34.84M 2024-12
Roche Holding CHF 27.02B 424M 2024-12
Siemens EUR 44.69B 778M 2024-12
Standard Biotools USD 65.89M 54.72M 2024-12
Thermo Fisher Scientific USD 13.33B 1.27B 2024-12
Tosoh JPY 363.56B 7.53B 2024-12
Waters USD 789.76M 26.28M 2024-12



Bio-Rad Laboratories Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.